Literature DB >> 21612755

Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study.

A Di Biagio1, R Rosso, F Vitale, F Cardinale, M P Sormani, G Secondo, L Di Stefano, C Viscoli.   

Abstract

OBJECTIVES: Renal dysfunction is a common complication in human immunodeficiency virus (HIV)-infected patients and can be attributed to direct viral damage, comorbidities or drug toxicity. The aim of this study was to assess cross-sectional correlates of renal damage in a contemporary European cohort of patients.
METHODS: We performed a case-control study from our cohort of 750 HIV-infected adults over a period of 5 months. We assessed renal damage by either proteinuria (≥+ on urine dipstick), reduced creatinine clearance (< 60 ml/min) or reduced estimated glomerular filtration rate (eGFR) of < 60 ml/ min/1.73 m2. The characteristics of cases and controls were compared in analysis and in multivariate logistic regression models with stepwise selection.
RESULTS: Approximately 50% of the screened 106 patients had a qualifying abnormality. Altogether, we identified 55 cases with 110 age- and gender-matched controls. Mean eGFR was 90.7 (4.8) for cases vs. 106.1 (2.3) ml/min/1.73 m2 for controls (p = 0.001). Cases had a longer duration of HIV infection, more complex regimen, longer exposure to antiretroviral therapy and a more frequent diagnosis of acquired immune-deficiency syndrome (AIDS) and hepatitis C virus (HCV) infection. In the logistic multivariate model, renal damage remained significantly associated with longer known duration of HIV infection (OR 2.88, 95% CI: 1.28 - 6.46, p = 0.01), AIDS defining condition (OR 1.09 95% CI: 1.03 - 1.16, p = 0.002) female gender (OR 2.01, 95% CI: 0.96 - 4.18, p = 0.06), and HCV infection (OR 2.12, 95% CI: 0.99 - 4.52, p = 0.05).
CONCLUSIONS: Duration, antiretroviral regimen and coincidental HCV impacted the frequency of renal abnormalities in our patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612755     DOI: 10.5414/cnp75518

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

2.  Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.

Authors:  Pedro Rodríguez Quesada; Laura López Esteban; Jimena Ramón García; Rocío Vázquez Sánchez; Teresa Molina García; Gabriel Gaspar Alonso-Vega; Javier Sánchez-Rubio Ferrández
Journal:  Int J Clin Pharm       Date:  2015-05-26

Review 3.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

4.  Chronic Kidney Disease and Associated Factors Among HIV/AIDS Patients on HAART in Ethiopia.

Authors:  Gizachew Ayele Manaye; Dejene Derseh Abateneh; Wondwossen Niguse
Journal:  HIV AIDS (Auckl)       Date:  2020-10-19

Review 5.  The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.

Authors:  Stefan D Baral; Susanne Strömdahl; Chris Beyrer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events.

Authors:  Cristina Gervasoni; Paola Meraviglia; Simona Landonio; Sara Baldelli; Serena Fucile; Laura Castagnoli; Emilio Clementi; Agostino Riva; Massimo Galli; Giuliano Rizzardini; Dario Cattaneo
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

7.  Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature.

Authors:  Michele Mirabella; Lucia Taramasso; Laura Ambra Nicolini; Rodolfo Russo; Claudio Viscoli; Antonio Di Biagio
Journal:  Clin Nephrol Case Stud       Date:  2018-10-26

8.  Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Authors:  Amanda Mocroft; Jacqueline Neuhaus; Lars Peters; Lene Ryom; Markus Bickel; Daniel Grint; Janak Koirala; Aleksandra Szymczak; Jens Lundgren; Michael J Ross; Christina M Wyatt
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.